tiprankstipranks
Vivoryon Therapeutics AG (DE:05Y)
:05Y
Germany Market

Vivoryon Therapeutics AG (05Y) Income Statement

Compare
28 Followers

Vivoryon Therapeutics AG Income Statement

Last quarter (Q2 2024), Vivoryon Therapeutics AG's total revenue was €0.00, a decrease of ― from the same quarter last year. In Q2, Vivoryon Therapeutics AG's net income was €-13.56M. See Vivoryon Therapeutics AG’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
€ -3.62M€ 0.00€ 10.76M€ 0.00€ 0.00
Gross Profit
€ -3.10M€ -161.00K€ 9.03M€ -146.00K€ -88.00K
Operating Expenses
€ 25.74M€ 28.97M€ 21.84M€ 15.87M€ 7.69M
Depreciation and Amortization
€ 167.00K€ 161.00K€ 165.00K€ 146.00K€ 88.00K
EBITDA
€ -28.35M€ -28.17M€ -12.03M€ -16.34M€ -7.63M
Operating Income
€ -28.84M€ -29.13M€ -12.81M€ -16.02M€ -7.77M
Other Income/Expenses
€ 261.00K€ 777.00K€ 575.00K€ -493.00K€ -49.00K
Pretax Income
€ -28.58M€ -28.36M€ -12.22M€ -16.51M€ -7.82M
Net Income
€ -28.34M€ -28.16M€ -12.65M€ -16.51M€ -7.82M
Per Share Metrics
Basic EPS
€ -1.12€ -1.28€ -0.63€ -0.83€ -0.62
Diluted EPS
€ -1.12€ -1.28€ -0.63€ -0.83€ -0.62
Weighted Average Shares Outstanding
25.24M 22.02M 20.00M 19.98M 12.55M
Weighted Average Shares Outstanding (Diluted)
25.24M 22.02M 20.00M 19.98M 12.55M
Currency in EUR

Vivoryon Therapeutics AG Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis